» Articles » PMID: 24254705

Tau Protein Provides DNA with Thermodynamic and Structural Features Which Are Similar to Those Found in Histone-DNA Complex

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2013 Nov 21
PMID 24254705
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Tau protein has been proposed as a trigger of Alzheimer's disease once it is hyperphosphorylated. However, the role that native tau forms play inside the neuronal nucleus remains unclear. In this work we present results concerning the interaction of tau protein with double-stranded DNA, single-stranded DNA, and also with a histone-DNA complex. The tau-DNA interaction results in a structure resembling the beads-on-a-string form produced by the binding of histone to DNA. DNA retardation assays show that tau and histone induce similar DNA retardation. A surface plasmon resonance study of tau-DNA interaction also confirms the minor groove of DNA as a binding site for tau, similarly to the histone binding. A residual binding of tau to DNA in the presence of Distamycin A, a minor groove binder, suggests the possibility that additional structural domains on DNA may be involved in tau interaction. Finally, DNA melting experiments show that, according to the Zipper model of helix-coil transition, the binding of tau increases the possibility of opening the DNA double helix in isolated points along the chain, upon increasing temperature. This behavior is analogous to histones and supports the previously reported idea that tau could play a protective role in stress situations. Taken together, these results show a similar behavior of tau and histone concerning DNA binding, suggesting that post-translational modifications on tau might impair the role that, by modulating the DNA function, might be attributable to the DNA-tau interaction.

Citing Articles

Tau here, tau there, tau almost everywhere: Clarifying the distribution of tau in the adult CNS.

Kanaan N Cytoskeleton (Hoboken). 2023; 81(1):107-115.

PMID: 38102924 PMC: 10851165. DOI: 10.1002/cm.21820.


Nuclear face of Tau: an inside player in neurodegeneration.

Younas N, Saleem T, Younas A, Zerr I Acta Neuropathol Commun. 2023; 11(1):196.

PMID: 38087392 PMC: 10714511. DOI: 10.1186/s40478-023-01702-x.


Untangling Tau: Molecular Insights into Neuroinflammation, Pathophysiology, and Emerging Immunotherapies.

Davidson R, Krider R, Borsellino P, Noorda K, Alhwayek G, Vida T Curr Issues Mol Biol. 2023; 45(11):8816-8839.

PMID: 37998730 PMC: 10670294. DOI: 10.3390/cimb45110553.


Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer's disease? From preclinical studies to the clinical trials.

Basheer N, Smolek T, Hassan I, Liu F, Iqbal K, Zilka N Mol Psychiatry. 2023; 28(6):2197-2214.

PMID: 37264120 PMC: 10611587. DOI: 10.1038/s41380-023-02113-z.


Phospho-Tau and Chromatin Landscapes in Early and Late Alzheimer's Disease.

Gil L, Nino S, Guerrero C, Jimenez-Capdeville M Int J Mol Sci. 2021; 22(19).

PMID: 34638632 PMC: 8509045. DOI: 10.3390/ijms221910283.